|
1
|
Gabius HJ: The Sugar Code Fundamentals of
Glycosciences. Wiley-VCH; Weinheim, Germany: 2009
|
|
2
|
Sperandio M: Selectins and
glycosyltransferases in leukocyte rolling in vivo. FEBS J.
273:4377–4389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
André S, Sanchez-Ruderisch H, Nakagawa H,
Buchholz M, Kopitz J, Forberich P, Kemmner W, Böck C, Deguchi K,
Detjen KM, Wiedenmann B, von Knebel Doeberitz M, Gress TM,
Nishimura S, Rosewicz S and Gabius HJ: Tumor suppressor
p16INK4a- modulator of glycomic profile and galectin-1
expression to increase susceptibility to carbohydrate-dependent
induction of anoikis in pancreatic carcinoma cells. FEBS J.
274:3233–3256. 2007.
|
|
4
|
Sanchez-Ruderisch H, Fischer C, Detjen KM,
Welzel M, Wimmel A, Manning JC, André S and Gabius HJ: Tumor
suppressor p16INK4a: downregulation of galectin-3, an
endogenous competitor of the pro-anoikis effector galectin-1, in a
pancreatic carcinoma model. FEBS J. 277:3552–3563. 2010.
|
|
5
|
Wu G, Lu ZH, Gabius HJ, Ledeen RW and
Bleich D: Ganglioside GM1 deficiency in effector T cells from NOD
mice induces resistance to regulatory T cell suppression. Diabetes.
60:2341–2349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Amano M, Eriksson H, Manning JC, Detjen
KM, André S, Nishimura SI, Lehtiö J and Gabius HJ: Tumour
suppressor p16INK4a: anoikis-favouring decrease in
N/O-glycan/cell surface sialylation by down-regulation of enzymes
in sialic acid biosynthesis in tandem in a pancreatic carcinoma
model. FEBS J. 279:4062–4080. 2012.PubMed/NCBI
|
|
7
|
Clark MC and Baum LG: T cells modulate
glycans on CD43 and CD45 during development and activation, signal
regulation, and survival. Ann NY Acad Sci. 1253:58–67. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu FT, Yang RY and Hsu DK: Galectins in
acute and chronic inflammation. Ann NY Acad Sci. 1253:80–91. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cooper DN: Galectinomics: finding themes
in complexity. Biochim Biophys Acta. 1572:209–231. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaltner H and Gabius HJ: A toolbox of
lectins for translating the sugar code: the galectin network in
phylogenesis and tumors. Histol Histopathol. 27:397–416.
2012.PubMed/NCBI
|
|
11
|
Haudek KC, Spronk KJ, Voss PG, Patterson
RJ, Wang JL and Arnoys EJ: Dynamics of galectin-3 in the nucleus
and cytoplasm. Biochim Biophys Acta. 1800.181–189. 2010.PubMed/NCBI
|
|
12
|
Smetana K Jr, Andre S, Kaltner H, Kopitz J
and Gabius HJ: Context-dependent multifunctionality of galectin-1:
a challenge for defining the lectin as therapeutic target. Expert
Opin Ther Targets. 17:379–392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Saussez S, Cucu DR, Decaestecker C,
Chevalier D, Kaltner H, André S, Wacreniez A, Toubeau G, Camby I,
Gabius HJ and Kiss R: Galectin-7 (p53-induced gene-1): a new
prognostic predictor of recurrence and survival in stage IV
hypopharyngeal cancer. Ann Surg Oncol. 13:999–1009. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saussez S, Decaestecker C, Lorfevre F,
Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ
and Leroy X: Increased expression and altered intracellular
distribution of adhesion/growth-regulatory lectins galectins-1 and
-7 during tumour progression in hypopharyngeal and laryngeal
squamous cell carcinomas. Histopathology. 52:483–493. 2008.
View Article : Google Scholar
|
|
15
|
Saussez S, Decaestecker C, Mahillon V,
Cludts S, Capouillez A, Chevalier D, Vet HK, Andre S, Toubeau G,
Leroy X and Gabius HJ: Galectin-3 upregulation during tumor
progression in head and neck cancer. Laryngoscope. 118:1583–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saussez S, de Leval L, Decaestecker C,
Sirtaine N, Cludts S, Duray A, Chevalier D, André S, Gabius HJ,
Remmelink M and Leroy X: Galectin fingerprinting in Warthin’s
tumors: lectin-bases approach to trace its origin? Histol
Histopathol. 25:541–550. 2010.
|
|
17
|
Cludts S, Decaestecker C, Mahillon V,
Chevalier D, Kaltner H, André S, Remmelink M, Leroy X, Gabius HJ
and Saussez S: Galectin-8 up-regulation during hypopharyngeal and
laryngeal tumor progression and comparison with galectin-1, -3 and
-7. Anticancer Res. 29:4933–4940. 2009.PubMed/NCBI
|
|
18
|
Remmelink M, de Leval L, Decaestecker C,
Duray A, Crompot E, Sirtaine N, André S, Kaltner H, Leroy X, Gabius
HJ and Saussez S: Quantitative immunohistochemical fingerprinting
of adhesion/growth-regulatory galectins in salivary gland tumours:
divergent profiles with diagnostic potential. Histopathology.
58:543–556. 2011. View Article : Google Scholar
|
|
19
|
Liu FT and Rabinovich G: Galectins as
modulators of tumour progression. Nat Rev Cancer. 5:29–41. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaltner H, Raschta AS, Manning JC and
Gabius HJ: Copy-number variation of functional galectin genes:
studying animal galectin-7 (p53-induced gene 1 in man) and
tandem-repeat-type galectins-4 and -9. Glycobiology. 23:1152–1163.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teclu A and Lacroix JS: Chronic
rhinosinusitis and nasal polyposis - a review. Otorinolaringol.
53:89–97. 2003.
|
|
22
|
Wood AJ and Douglas RG: Pathogenesis and
treatment of chronic rhinosinusitis. Postgrad Med J. 86:359–364.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Georgy MS and Peters AT: Chapter 8:
Rhinosinusitis. Allergy Asthma Proc. 33:24–27. 2012. View Article : Google Scholar
|
|
24
|
Sok JC and Ferguson BJ: Differential
diagnosis of eosinophilic chronic rhinosinusitis. Clin Allergy
Immunol. 19:69–85. 2007.PubMed/NCBI
|
|
25
|
Takeno S, Hirakawa K and Ishino T:
Pathological mechanisms and clinical features of eosinophilic
chronic rhinosinusitis in the Japanese population. Allergol Int.
59:247–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferguson BJ: Categorization of
eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head
Neck Surg. 12:237–242. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Delbrouck C, Gabius HJ, Kaltner H,
Decaestecker C, Kiss R and Hassid S: Expression patterns of
galectin-1 and galectin-3 in nasal polyps and middle and inferior
turbinates in relation to growth regulation and immunosuppression.
Arch Otolaryngol Head Neck Surg. 129:665–669. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Georgy MS and Peters AT: Chapter 7: Nasal
polyps. Allergy Asthma Proc. 33:22–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng W, Zheng C, Tian J and Shi G: T
helper cell population and eosinophilia in nasal polyps. J Investig
Allergol Clin Immunol. 17:297–301. 2007.PubMed/NCBI
|
|
30
|
Tomassen P, Van Zele T, Zhang N,
Perez-Novo C, Van Bruaene N, Gevaert P and Bachert C:
Pathophysiology of chronic rhinosinusitis. Proc Am Thorac Soc.
8:115–120. 2011. View Article : Google Scholar
|
|
31
|
Nadir H, Prades JM, Dumoliard JM and
Martin CH: Papillomes inverses des cavités naso-sinusiennes: A
propos de 19 patients. Journal Français d’oto-rhino-laryngologie.
52:81–86. 2003.(In French).
|
|
32
|
Anari S and Carrie S: Sinonasal inverted
papilloma: narrative review. J Laryngol Otol. 124:705–715. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brasnu D, Ayache D, Hans S, Hartl D and
Papon JF: Traité d’ORL. Flammarion, Paris: pp. 212–220. 2008
|
|
34
|
Altavilla G, Staffieri A, Busatto G,
Canesso A, Giacomelli L and Marioni G: Expression of p53,
p16INK4A, pRB, p21WAF1/CIP1,
p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal
endophytic Schneiderian (inverted) papilloma. Acta Otolaryngol.
129:1242–1249. 2009.
|
|
35
|
Thompson LDR: Head and Neck Pathology.
Churchill Livingstone/Elsevier; Philadelphia: pp. 124–132. pp.
155–160. 2006
|
|
36
|
Kopitz J, André S, von Reitzenstein C,
Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu FT,
Cantz M, Heck AJ and Gabius HJ: Homodimeric galectin-7 (p53-induced
gene 1) is a negative growth regulator for human neuroblastoma
cells. Oncogene. 22:6277–6288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Purkrábková T, Smetana K Jr, Dvoránková B,
Holíková Z, Böck C, Lensch M, André S, Pytlík R, Liu FT, Klíma J,
Smetana K, Motlik J and Gabius HJ: New aspects of galectin
functionality in nuclei of cultured bone marrow stromal and
epidermal cells: biotinylated galectins as tool to detect specific
binding sites. Biol Cell. 95:535–545. 2003.PubMed/NCBI
|
|
38
|
Langbein S, Brade J, Badawi JK, Hatzinger
M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P and
Gabius HJ: Gene-expression signature of adhesion/growth-regulatory
tissue lectins (galectins) in transitional cell cancer and its
prognostic relevance. Histopathology. 51:681–690. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kaltner H, Kübler D, López-Merino L, Lohr
M, Manning JC, Lensch M, Seidler J, Lehmann WD, André S, Solís D
and Gabius HJ: Toward comprehensive analysis of the galectin
network in chicken: unique diversity of galectin-3 and comparison
of its localization profile in organs of adult animals to the other
four members of this lectin family. Anat Rec. 294:427–444. 2011.
View Article : Google Scholar
|
|
40
|
Fík Z, Valach J, Chovanec M, Mazánek J,
Kodet R, Kodet O, Tachezy R, Foltynova E, André S, Kaltner H,
Gabius HJ and Smetana K Jr: Loss of adhesion/growth-regulatory
galectin-9 from squamous cell epithelium in head and neck
carcinomas. J Oral Pathol Med. 42:166–1673. 2013.PubMed/NCBI
|
|
41
|
Saal I, Nagy N, Lensch M, Lohr M, Manning
JC, Decaestecker C, André S, Kiss R, Salmon I and Gabius HJ: Human
galectin-2: expression profiling by RT-PCR/immunohistochemistry and
its introduction as histochemical tool for ligand localization.
Histol Histopathol. 20:1191–1208. 2005.PubMed/NCBI
|
|
42
|
Lohr M, Kaltner H, Lensch M, André S,
Sinowatz F and Gabius HJ: Cell-type-specific expression of murine
multifunctional galectin-3 and its association with follicular
atresia/luteolysis in contrast to pro-apoptotic galectins-1 and -7.
Histochem Cell Biol. 130:567–581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sarter K, Janko C, Andre S, Munoz LE,
Schorn C, Winkler S, Rech J, Kaltner H, Lorenz HM, Schiller M,
Andreoli L, Manfredi AA, Isenberg DA, Schett G, Herrmann M and
Gabius HJ: Autoantibodies against galectins are associated with
antiphospholipid syndrome in patients with systemic lupus
erythematosus. Glycobiology. 23:12–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Danguy A, Rorive S, Decaestecker C,
Bronckart Y, Kaltner H, Hadari YR, Goren R, Zich Y, Petein M,
Salmon I, Gabius HJ and Kiss R: Immunohistochemical profile of
galectin-8 expression in benign and malignant tumors of epithelial,
mesenchymatous and adipous origins, and of the nervous system.
Histol Histopathol. 16:861–868. 2001.PubMed/NCBI
|
|
45
|
Wang JL, Gray RM, Haudek KC and Patterson
RJ: Nucleocytoplasmic lectins. Biochim Biophys Acta. 1673:75–93.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rubinstein N, Ilarregui JM, Toscano MA and
Rabinovich GA: The role of galectins in the initiation,
amplification and resolution of the inflammatory response. Tissue
Antigens. 64:1–12. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sena AAS, Provazzi PJS, Fernandes AM, Cury
PM, Rahal P and Oliani SM: Spatial expression of two
anti-inflammatory mediators, annexin 1 and galectin-1, in nasal
polyposis. Clin Exp Allergy. 36:1260–1267. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Iino Y, Miyazama T, Kakizaki K, Saigusa H,
Katano H, Shiga J and Kanegasaki S: Expression of ecalectin, a
novel eosinophil chemoattractant, in nasal polyps. Acta
Otolaryngol. 126:43–50. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Matsuura A, Tsukada J, Mizobe T, Higashi
T, Mouri F, Tanikawa R, Yamauchi A, Hirashima M and Tanaka Y:
Intracellular galectin-9 activates inflammatory cytokines in
monocytes. Genes Cells. 14:511–521. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Nobumoto A, Nagahara K, Oomizu S, Katoh S,
Nishi N, Takeshita K, Niki T, Tominaga A, Yamauchi A and Hirashima
M: Galectin-9 suppresses tumor metastasis by blocking adhesion to
endothelium and extracellular matrices. Glycobiology. 18:735–744.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pioche-Durieu C, Keryer C, Souquere S,
Bosq J, Faigle W, Loew D, Hirashima M, Nishi N, Middeldorp J and
Busson P: In nasopharyngeal carcinoma cells, Epstein-Barr virus
LMP1 interacts with galectin 9 in membrane raft elements resistant
to simvastatin. J Virol. 79:13326–13337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Keryer-Bibens C, Pioche-Durieu C,
Villemant C, Souquere S, Nishi N, Hirashima M, Middeldorp J and
Busson P: Exosomes released by EBV-infected nasopharyngeal
carcinoma cells convey the viral latent membrane protein 1 and the
immunomodulatory protein galectin 9. BMC Cancer. 6:2832006.
View Article : Google Scholar
|
|
53
|
Klibi J, Niki T, Riedel A, Pioche-Durieu
C, Souquere S, Rubinstein E, Le Moulec S, Guigay J, Hirashima M,
Guemira F, Adhikary D, Mautner J and Busson P: Blood diffusion and
Th1-suppressive effects of galectin-9-containing exosomes released
by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.
Blood. 113:1957–1966. 2009. View Article : Google Scholar
|
|
54
|
Hadari YR, Arbel-Goren R, Levy Y,
Amsterdam A, Alon R, Zakut R and Zick Y: Galectin-8 binding to
integrins inhibits cell adhesion and induces apoptosis. J Cell Sci.
113:2385–2397. 2000.PubMed/NCBI
|
|
55
|
Saussez S, Lorfevre F, Nonclercq D,
Laurent G, André S, Journé F, Kiss R, Toubeau G and Gabius HJ:
Towards functional glycomics by localization of binding sites for
tissue lectins: lectin histochemical reactivity for galectins
during diethylstilbestrol-induced kidney tumorigenesis in male
Syrian hamster. Histochem Cell Biol. 126:57–69. 2006. View Article : Google Scholar
|
|
56
|
Vansthertem D, Cludts S, Nonclercq D,
Gossiaux A, Saussez S, Legrand A, Gabius HJ and Toubeau G:
Immunohistochemical localization of galectins-1 and -3 and
monitoring of tissue galectin-binding sites during tubular
regeneration after renal ischemia reperfusion in the rat. Histol
Histopathol. 25:1417–1429. 2010.
|
|
57
|
Dawson H, André S, Karamitopoulou E,
Zlobec I and Gabius HJ: The growing galectin network in colon
cancer and clinical relevance of cytoplasmic galectin-3 reactivity.
Anticancer Res. 33:3053–3059. 2013.PubMed/NCBI
|
